Next Challenge for AI in Pharma: Connecting Data, Systems and Workflows
AI in pharma is expanding across drug discovery, clinical development, real-world evidence, pharmacovigilance, commercial operations, and digital healthcare. But as pharmaceutical companies adopt more specialized AI technologies, another challenge is becoming harder to ignore: connecting those technologies with the data, systems, and workflows already running the business. A pharmaceutical organization may use one platform for molecular research, another for clinical trials, another for real-world evidence, and different systems for regulatory, commercial, and patient-facing operations. Each platform may solve a specific problem well. The difficulty starts when the information generated by one system needs to become useful somewhere else. That is where the next phase of pharmaceutical AI becomes interesting. The competitive advantage may not come from simply having more AI tools. It may come from how effectively those tools work together . AI in Pharma Is Becoming an Ecosystem The...